You are here

Innovative Healthcare Committee


The IHC aims to be a reliable policy partner to the Belgian government and local US embassy to Belgium to ensure that new healthcare-related legislation and policies add value to, and benefit, the entire healthcare ecosystem.

The IHC is a unique cross-functional body covering nearly the whole health industry in Belgium. It contributes to ongoing legislative and policy discussions by:

  • Promoting the regular exchange of viewpoints between large companies and federal and regional officials on important healthcare challenges (ageing, economic crisis, patients expectations ...)
  • Ensuring efficient coordination of regionalized matters in the three Regions, prioritizing healthcare interests as State Reform is implemented

It also will be able to support the Healthcare Committee of AmCham EU to ensure that health is seen as an important driver for wealth and economic growth; it therefore supports the EU health agenda towards affordable, sustainable and innovative health systems.


  • Give Government/Public Affairs Managers and subject matter specialists of AmCham Belgium members a forum to exchange views with Belgian officials and US embassy officials.
  • Engage in constructive, high-level discussions with Belgian policymakers and US officials from the federal and regional governments on relevant topics
  • Promote a vigorous debate on the merits of building healthcare priorities/issues and investing in Belgium among the broader AmCham Belgium membership
  • Be a partner to the AmCham EU Healthcare committee and promote the sharing of local learnings/best practices amongst European countries, possibly leveraging an annual AmCham EU meeting with local AmChams (and engage/educate US embassies’ officers across Europe on key healthcare policy issues).

Committee members

Ms. Olivia Natens

Country Director Belux, Medtronic Belgium NV/SA

Mr. Joan Van Loon

Belux Enterprise Business Unit Leader Public, Life Sciences, Telco & Utilities, IBM Belgium BVBA/SPRL
Vice Chair

Ms. Kathleen Commers

Public Affairs Manager, Pfizer NV/SA
Vice Chair

Mr. Benjamin Baelus

Government Affairs Manager, AbbVie SA
Vice Chair

Mr. Philip Alliet

CEO Belux, Aon Belgium BVBA (Diegem)

Mr. Timmy Boerjan

Market Access Head, Baxter Belgium SPRL

Mr. Peter Bogaert

Managing Partner, Covington & Burling LLP

Mr. Kristof Callebaut

Managing Director – Country Manager Belux, GE Healthcare

Ms. Laura Capitaine

Policy Analyst, Johnson & Johnson Medical NV

Mr. Frédéric Clais

Country Manager, Eli Lilly Benelux NV/SA

Mr. Rémi Delépine

Country Coordinator Belgium; Health Economics & Market Access, Belgium, Boston Scientific Benelux NV

Mr. Jan Denecker

Marketing Manager Healthcare, UPS Belgium NV (Diegem)

Mr. Jason Donohue

Principal - Healthcare Practice Lead, i-Propeller NV/SA

Ms. Danny Dumon

Commercial Advisor, US Embassy

Mr. Dirk Hemelsoet

Policy & Government Relations Manager, MSD Belgium BVBA/SPRL

Mr. Antoine Mialhe

Managing Director, Strategic Communications (Healthcare & Lifesciences), FTI Consulting

Ms. Michèle Paque

Head West Europe Integrated Engagement Services, IQVIA RDS & Integrated Services Belgium

Mr. Kris Schellens

Managing Director BeLux, Biogen Belgium NV

Mr. Bruno Schröder

National Technology Officer, Microsoft Belux, Microsoft NV

Mr. Christophe Steenhaut

Product Consultant, 3M Belgium (Diegem)

Mr. Bart Torbeyns

Head Public Affairs, Sanofi Belgium NV

Mr. Johan Vanhoyland

Managing Director Sector Head Technology, Media, Telecom & Healthcare, ING Belgium NV/SA (Marnix)

Mr. Vincent Vanwijnsberghe

External Affairs Manager, Alcon NV

Ms. Johanna Vijverman

Policy Officer, AmCham Belgium
Staff Liaison